about
Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic DiseasesMiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosisIL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics.Corrigendum: IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics.Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis.Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein.Emerging role of epigenetics in systemic sclerosis pathogenesis.Current frontiers in systemic sclerosis pathogenesis.Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-κB.Histone Demethylation and Toll-like Receptor 8-Dependent Cross-Talk in Monocytes Promotes Transdifferentiation of Fibroblasts in Systemic Sclerosis Via Fra-2.Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors.The role of microRNA-5196 in the pathogenesis of systemic sclerosis.Targeting interferons as a strategy for systemic sclerosis treatment.Age-related changes in the occurrence and characteristics of thymic CD4(+) CD25(+) T cells in miceChanges in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis PatientsB lymphocytes acquire and present intracellular antigens that have relocated to the surface of apoptotic target cellsCpG-specific methylation at rheumatoid arthritis diagnosis as a marker of treatment responseGlobal miRNA and mRNA expression profiles identify miRNA-26a-2-3p-dependent repression of IFN signature in systemic sclerosis human monocytesDNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
P50
Q28079715-CBBF02E6-D1A5-4434-9294-203B659A2AB9Q34790405-17B2B286-E0A5-475B-AA54-0B4D853F53F4Q36835532-E8585701-4CE8-4110-B1CD-D965CF08E235Q36991274-5243A9DA-0655-47C5-89FC-5BAE42361F26Q37678055-7C41998C-D34B-42F7-B724-0DD1A711157FQ37683419-00A62B96-7EDD-4F49-A3DA-FE3410A85A60Q38230244-0478A735-CF0A-4E5E-87FB-298E49AD73B0Q38364957-898CD4C5-1A25-44BA-B267-188DF816169EQ39029262-F0498959-F45B-4F5F-8234-1F4F0A9AB8B9Q40057489-28E72A32-50FA-498D-A05F-D1CF06FDEF5DQ43091811-55C8B80E-E682-4D3A-8019-D0311A3C3A47Q46346274-4AE3FCBA-D9DF-4866-932B-4B86308123C0Q47589652-BF5901B7-1E30-4CBA-A15E-EF153E24E00BQ56901055-39F59484-8BE0-4BBE-9A8D-A017BF76A42DQ61919255-82CD7779-07CE-433F-9403-1987CF6D2CB2Q84136510-B77470FA-CCA8-419E-9BBC-CCEF55E5F6E5Q87928401-E6B193F3-C57B-4AF4-B81B-90562C4E695EQ89840666-B0518D56-2585-4B90-9FC3-039C22C7AEA1Q92825928-0A83CBAA-CEA0-4FD8-A3EA-B4229D39AA3D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marzena Ciechomska
@ast
Marzena Ciechomska
@en
Marzena Ciechomska
@es
Marzena Ciechomska
@nl
Marzena Ciechomska
@sl
type
label
Marzena Ciechomska
@ast
Marzena Ciechomska
@en
Marzena Ciechomska
@es
Marzena Ciechomska
@nl
Marzena Ciechomska
@sl
prefLabel
Marzena Ciechomska
@ast
Marzena Ciechomska
@en
Marzena Ciechomska
@es
Marzena Ciechomska
@nl
Marzena Ciechomska
@sl
P108
P106
P108
P21
P31
P496
0000-0002-0961-6130